Author

B. J. Backes

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

F. R. Papa· 2 shared M. Thamsen· 2 shared A. Brumwell· 1 shared A. Hiniker· 1 shared A. K. Shum· 1 shared C. S. Law· 1 shared D. J. Maly· 1 shared D. Sheppard· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

F. R. Papa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

IRE1α drives lung epithelial progenitor dysfunction to establish a niche for pulmonary fibrosis

V. C. Auyeung, M. S. Downey, J. J. Kathiriya, M. Thamsen, T. A. Wenger, B. J. Backes, A. Brumwell, H. A. Chapman, D. Sheppard, F. R. Papa

This study shows that IRE1α inhibition reduces ER stress and TGFβ signaling in lung epithelial cells, decreasing fibrosis by targeting damage-associated progenitors.

bioRxiv · Sep 16, 2021Cell Biology

A defect in COPI-mediated transport of STING causes immune dysregulation in COPA syndrome

A. K. Shum, Z. Deng, Z. Chong, C. S. Law, K. Mukai, F. O. Ho, T. Martinu, B. J. Backes, W. L. Eckalbar, T. Taguchi

This study shows that defective COPI transport of STING due to COPA mutations leads to immune dysregulation and type I interferon signaling in COPA syndrome.

bioRxiv · May 20, 2020Immunology

Parallel signaling through IRE1α and PERK regulates pancreatic neuroendocrine tumor growth and survival

P. C. Moore, J. Y. Qi, M. Thamsen, R. Ghosh, J. Peng, M. J. Gliedt, R. Meza-Acevedo, R. E. Warren, A. Hiniker, G. E. Kim, D. J. Maly, B. J. Backes, F. R. Papa, S. A. Oakes

This study shows that targeting the UPR components IRE1α and PERK can inhibit pancreatic neuroendocrine tumor growth by inducing apoptosis through reciprocal signaling.

bioRxiv · Sep 18, 2019Cancer Biology